戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 eal cancer among the women who had undergone prophylactic surgery.
2 nography examinations within 6 months before prophylactic surgery.
3 esults tended to reinforce intentions toward prophylactic surgery.
4  only if all women who test positive undergo prophylactic surgery.
5 ocumented the occurrence of cancer following prophylactic surgery.
6  mm appears to be a reasonable threshold for prophylactic surgery.
7 ront modern combination chemotherapy without prophylactic surgery.
8         Among unaffected women with no prior prophylactic surgery, 17% of carriers (2/12) intended to
9 e who completed testing surveyed interest in prophylactic surgery after counseling and receiving test
10                      Additionally, elective 'prophylactic' surgery after diverticulitis, previously c
11 ectomy and prophylactic oophorectomy with no prophylactic surgery among women who carry mutations in
12 RCA2 (BRCA1/2) mutations must choose between prophylactic surgeries and screening to manage their hig
13 ion in cancer incidence and mortality due to prophylactic surgeries and/or tamoxifen were estimated f
14 e expectancy decline with age at the time of prophylactic surgery and are minimal for 60-year-old wom
15 h BRCA1/2 mutations in their choices between prophylactic surgery and breast screening.
16      The individual patient's choice between prophylactic surgery and surveillance is a complex decis
17 ondary cancer prevention strategies, such as prophylactic surgery and tamoxifen therapy.
18                      Women who had undergone prophylactic surgery and their matched controls were fol
19 finding cancer in these women at the time of prophylactic surgery, and careful pathologic assessment
20 ailable to them, including watchful waiting, prophylactic surgery, and chemoprevention.
21 ective estrogen receptor modulators (SERMs), prophylactic surgery, and lifestyle change.
22 inical and genetic indications and timing of prophylactic surgery, and the efficacy of prophylactic s
23 eling providers predicted they would opt for prophylactic surgery at a young age if they carried a BR
24 positive for a BRCA1 or BRCA2 gene mutation, prophylactic surgery at a young age substantially improv
25 dy updates findings regarding the effects of prophylactic surgery, chemoprevention, and surveillance
26     No recommendation is made for or against prophylactic surgery (eg, mastectomy, oophorectomy); the
27 nd angiotensin-converting enzyme inhibitors; prophylactic surgery for aneurysm; surgical techniques f
28 reviewed from BRCA-positive women undergoing prophylactic surgery for ovarian cancer risk reduction w
29 etic testing, colonoscopic surveillance, and prophylactic surgery for the relatives of index cases.
30     No recommendation is made for or against prophylactic surgery (ie, colectomy, hysterectomy); thes
31 urgery as well as the current guidelines for prophylactic surgery in high-risk mutation carriers are
32 y 2007, 122 BRCA-positive patients underwent prophylactic surgery in the Division of Gynecologic Onco
33                                              Prophylactic surgery is cost-effective for years of life
34                                              Prophylactic surgery is generally not recommended for av
35 ; options to reduce cancer mortality include prophylactic surgery or breast screening, but their effi
36 n carriers, decision analysis indicates that prophylactic surgery or chemoprevention leads to better
37 an previously reported from chemoprevention, prophylactic surgery, or a combination.
38 idence of cancer, prognosis, and efficacy of prophylactic surgery, our model suggests that prophylact
39 ng depression, functional health status, and prophylactic surgery plans [follow-up only]) were assess
40  referral of selected high-risk patients for prophylactic surgery prevents development of CRC in SPS
41                     Observational studies of prophylactic surgeries report reduced risks for breast a
42 nt colorectal cancer begun in the 1960s) and prophylactic surgeries, such as in Lynch syndrome patien
43 nt rates of germline testing, screening, and prophylactic surgery, the strategies reduced deaths from
44 rated the ability of molecular diagnosis and prophylactic surgery to improve patient outcomes.
45 participation in chemoprevention trials, and prophylactic surgery to remove at-risk tissues.
46                                              Prophylactic surgeries were cost-effective compared with
47 ed risks for breast and ovarian cancer after prophylactic surgeries were obtained from the literature
48 of prophylactic surgery, and the efficacy of prophylactic surgery when known.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。